Evidence map›Paper›PMID 26396248›Full record

ArticlemBio2015

Virome Capture Sequencing Enables Sensitive Viral Diagnosis and Comprehensive Virome Analysis.

Thomas Briese, Amit Kapoor, Nischay Mishra, Komal Jain, Arvind Kumar, Omar J Jabado, W Ian Lipkin

Erratum issued 2 registry-linked trialsAbstract readEvaluation Study
In one paragraph

Article in mBio, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 2 registered trials, which are not on this map. Cited by 239 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
239citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02836886 completednot on this mapstarted 2016, after this paper: background citation

Searching for Oncogenic Viruses in Sézary Cells Using a Novel Viral Discovery Technique, VirCapSeq-VERT

TypeobservationalSponsorColumbia UniversityRan2016 to 2016Enrolled6ConditionsLymphoma, T-Cell, Cutaneous, Sézary Syndrome
NCT07626073 enrolling by invitationnot on this mapstarted 2023, after this paper: background citation

h Can Provide the Detection Results of Pathogen Type and Resistant Gene. This Study is a Prospective Multi Centers Study to Explore Using the New Diagnostic Tool of " RPIP " and the Different Detection Methods of Next Generation Sequencing and Multiplex PC R in Patients With Pneumonia in ICU. Further Compare the Difference of Pathogen Identification and Clinical Impact by Different Diagnostic Methods.

Typeobservational_patient_registrySponsorChina Medical University HospitalRan2023 to 2028Enrolled200ConditionsRespiratory Pathogens
3 · Its place in the literature

Who cites it

239 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Enrichment techniques for clinical metagenomics.Frontiers in cellular and infection microbiology · 2026
    Review
  18. Review
  19. Article
  20. Review

179 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Thomas BrieseCenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA Department of Epidemiology, Mailman School of Public Columbia University, New York, New York, USA.
Amit KapoorCenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA Department of Pathology and Cell Biology, College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Nischay MishraCenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA.
Komal JainCenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA.
Arvind KumarCenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA.
Omar J JabadoCenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA.
W Ian LipkinCenter for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA Department of Epidemiology, Mailman School of Public Columbia University, New York, New York, USA Department of Pathology and Cell Biology, College of Physicians and Surgeons, Columbia University, New York, New York, USA Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, New York, USA wil2001@columbia.edu.

Funding

Translational CoreU19AI109761 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI RELMAN, DAVID A. · 2014 to 2018
$32.6M
Novel viruses and viral dynamics in multiple transfusion recipientsR01HL119485 · NHLBI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI KAPOOR, AMIT · 2014 to 2018
$2.0M
NHLBI NIH HHS R01 HL119485NIAID NIH HHS U19 AI109761
6 · The paper itself

Abstract

Insensitivity and technical complexity have impeded the implementation of high-throughput nucleic acid sequencing in differential diagnosis of viral infections in clinical laboratories. Here, we describe the development of a virome capture sequencing platform for vertebrate viruses (VirCapSeq-VERT) that increases the sensitivity of sequence-based virus detection and characterization. The system uses ~2 million probes that cover the genomes of members of the 207 viral taxa known to infect vertebrates, including humans. A biotinylated oligonucleotide library was synthesized on the NimbleGen cleavable array platform and used for solution-based capture of viral nucleic acids present in complex samples containing variable proportions of viral and host nucleic acids. The use of VirCapSeq-VERT resulted in a 100- to 10,000-fold increase in viral reads from blood and tissue homogenates compared to conventional Illumina sequencing using established virus enrichment procedures, including filtration, nuclease treatments, and RiboZero rRNA subtraction. VirCapSeq-VERT had a limit of detection comparable to that of agent-specific real-time PCR in serum, blood, and tissue extracts. Furthermore, the method identified novel viruses whose genomes were approximately 40% different from the known virus genomes used for designing the probe library. The VirCapSeq-VERT platform is ideally suited for analyses of virome composition and dynamics. IMPORTANCE : VirCapSeq-VERT enables detection of viral sequences in complex sample backgrounds, including those found in clinical specimens, such as serum, blood, and tissue. The highly multiplexed nature of the system allows both the simultaneous identification and the comprehensive genetic characterization of all known vertebrate viruses, their genetic variants, and novel viruses. The operational simplicity and efficiency of the VirCapSeq-VERT platform may facilitate transition of high-throughput sequencing to clinical diagnostic as well as research applications.

Indexed as

MicrobiotaAnimalsHigh-Throughput Nucleotide SequencingHumansNucleic Acid HybridizationOligonucleotide ProbesVertebratesVirologyVirus DiseasesVirusesOligonucleotide Probes

Identifiers

PMID26396248
PMCPMC4611031

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.